Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- ACXP
- Price
- 11.00
- Stock movement down
- -3.40 (-23.61%)
- Company name
- Acurx Pharmaceuticals LLC
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 17.43M
- Ent value
- 14.99M
- Price/Sales
- -
- Price/Book
- 6.54
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -76.89%
- 3 year return
- -47.59%
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-08-27
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
ACXP does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 6.54 |
| EV to Sales | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 1.58M |
| EPS (TTM) | -173.26 |
| FCF per share (TTM) | -497.28 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | -16.44M |
| Net income (TTM) | -2.84B |
| EPS (TTM) | -173.26 |
| EPS (1y forward) | -4.59 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 5.76M |
| Net receivables | 97.37K |
| Total current assets | 5.98M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 5.98M |
| Accounts payable | 0.00 |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 3.32B |
| Total liabilities | 3.32M |
| Shareholder's equity | 2.66M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -8.14B |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -8.14B |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -106427.09% |
| Return on Assets | -47389.70% |
| Return on Invested Capital | -106427.09% |
| Cash Return on Invested Capital | -214748.36% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 13.60 |
| Daily high | 13.70 |
| Daily low | 11.00 |
| Daily Volume | 179K |
| All-time high | 157.80 |
| 1y analyst estimate | 61.70 |
| Beta | -1.26 |
| EPS (TTM) | -173.26 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 18 Nov 2025 |
Downside potential
Loading...
Downside potential data
| ACXP | S&P500 | |
| Current price drop from All-time high | -93.03% | -3.04% |
| Highest price drop | -96.13% | -56.47% |
| Date of highest drop | 13 Jun 2025 | 9 Mar 2009 |
| Avg drop from high | -62.47% | -11.04% |
| Avg time to new high | 501 days | 12 days |
| Max time to new high | 1001 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
17.43M
Marketcap category
Small-cap
Description
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia; and CCP, multiple product candidates for gram-positive infections. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.
Employees
4
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page